nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—epilepsy syndrome—migraine	0.249	1	CtDrD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Valproic Acid—migraine	0.164	0.5	CiPCiCtD
Topiramate—Decreased Central Nervous System Disorganized Electrical Activity—Gabapentin—migraine	0.164	0.5	CiPCiCtD
Topiramate—SCN1A—migraine	0.131	1	CbGaD
Topiramate—bipolar disorder—Valproic Acid—migraine	0.0966	0.569	CpDpCtD
Topiramate—bipolar disorder—Gabapentin—migraine	0.0732	0.431	CpDpCtD
Topiramate—SCN5A—Verapamil—migraine	0.0139	0.31	CbGbCtD
Topiramate—CYP2C19—Timolol—migraine	0.00569	0.127	CbGbCtD
Topiramate—CYP2C19—Propranolol—migraine	0.00508	0.114	CbGbCtD
Topiramate—CYP2C19—Amitriptyline—migraine	0.00439	0.0982	CbGbCtD
Topiramate—CYP2C19—Valproic Acid—migraine	0.004	0.0895	CbGbCtD
Topiramate—CYP2C19—Verapamil—migraine	0.00348	0.0779	CbGbCtD
Topiramate—CA5B—cervicothoracic ganglion—migraine	0.00257	0.118	CbGeAlD
Topiramate—CYP3A4—Propranolol—migraine	0.00245	0.0549	CbGbCtD
Topiramate—CYP3A4—Amitriptyline—migraine	0.00212	0.0475	CbGbCtD
Topiramate—CYP3A4—Valproic Acid—migraine	0.00193	0.0433	CbGbCtD
Topiramate—CYP3A4—Verapamil—migraine	0.00168	0.0377	CbGbCtD
Topiramate—GRIK1—peripheral nervous system—migraine	0.00112	0.0515	CbGeAlD
Topiramate—GRIA4—nerve—migraine	0.000994	0.0458	CbGeAlD
Topiramate—GRIK1—nerve—migraine	0.000872	0.0401	CbGeAlD
Topiramate—GRIA3—nerve—migraine	0.000811	0.0373	CbGeAlD
Topiramate—SCN1A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000465	0.0408	CbGpPWpGaD
Topiramate—GRIK3—trigeminal ganglion—migraine	0.000445	0.0205	CbGeAlD
Topiramate—GRIK5—trigeminal ganglion—migraine	0.000445	0.0205	CbGeAlD
Topiramate—GRIA1—nerve—migraine	0.000433	0.0199	CbGeAlD
Topiramate—GRIA4—brainstem—migraine	0.000427	0.0197	CbGeAlD
Topiramate—GRIK5—Neuronal System—KCNK18—migraine	0.000424	0.0372	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—KCNK18—migraine	0.000424	0.0372	CbGpPWpGaD
Topiramate—GRIK1—trigeminal ganglion—migraine	0.000423	0.0195	CbGeAlD
Topiramate—GRIK1—Neuronal System—KCNK18—migraine	0.000394	0.0346	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—KCNK18—migraine	0.000394	0.0346	CbGpPWpGaD
Topiramate—GRIK5—brainstem—migraine	0.000394	0.0181	CbGeAlD
Topiramate—SCN5A—Interaction between L1 and Ankyrins—SCN1A—migraine	0.000384	0.0337	CbGpPWpGaD
Topiramate—GRIK1—brainstem—migraine	0.000374	0.0172	CbGeAlD
Topiramate—GRIA4—Neuronal System—KCNK18—migraine	0.000335	0.0294	CbGpPWpGaD
Topiramate—SCN5A—Interaction between L1 and Ankyrins—SCN2A—migraine	0.000327	0.0287	CbGpPWpGaD
Topiramate—GABRB2—Ligand-gated ion channel transport—HTR3A—migraine	0.000313	0.0275	CbGpPWpGaD
Topiramate—GRIK2—nerve—migraine	0.000311	0.0143	CbGeAlD
Topiramate—GRIK4—head—migraine	0.000298	0.0137	CbGeAlD
Topiramate—GABRG2—Ligand-gated ion channel transport—HTR3A—migraine	0.000286	0.0252	CbGpPWpGaD
Topiramate—GRIK4—nervous system—migraine	0.000283	0.013	CbGeAlD
Topiramate—GRIK4—central nervous system—migraine	0.000272	0.0125	CbGeAlD
Topiramate—GRIK4—Transmission across Chemical Synapses—CACNA1A—migraine	0.00027	0.0237	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—CACNA1A—migraine	0.00027	0.0237	CbGpPWpGaD
Topiramate—GRIK4—cerebellum—migraine	0.000266	0.0123	CbGeAlD
Topiramate—GRIK3—Transmission across Chemical Synapses—CACNA1A—migraine	0.000251	0.0221	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000251	0.0221	CbGpPWpGaD
Topiramate—GABRA1—Ligand-gated ion channel transport—HTR3A—migraine	0.00025	0.022	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—KCNK18—migraine	0.000243	0.0214	CbGpPWpGaD
Topiramate—GRIA4—head—migraine	0.000236	0.0109	CbGeAlD
Topiramate—CA1—nerve—migraine	0.00023	0.0106	CbGeAlD
Topiramate—GRIA4—nervous system—migraine	0.000224	0.0103	CbGeAlD
Topiramate—GRIK5—head—migraine	0.000218	0.01	CbGeAlD
Topiramate—GRIK3—head—migraine	0.000218	0.01	CbGeAlD
Topiramate—GRIK4—brain—migraine	0.000216	0.00996	CbGeAlD
Topiramate—GRIA4—central nervous system—migraine	0.000215	0.00991	CbGeAlD
Topiramate—GRIA4—Transmission across Chemical Synapses—CACNA1A—migraine	0.000214	0.0188	CbGpPWpGaD
Topiramate—GRIA4—cerebellum—migraine	0.00021	0.00969	CbGeAlD
Topiramate—GRIK5—Neuronal System—CACNA1A—migraine	0.000207	0.0182	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—CACNA1A—migraine	0.000207	0.0182	CbGpPWpGaD
Topiramate—GRIK1—head—migraine	0.000207	0.00952	CbGeAlD
Topiramate—GRIK5—nervous system—migraine	0.000206	0.0095	CbGeAlD
Topiramate—GRIK3—nervous system—migraine	0.000206	0.0095	CbGeAlD
Topiramate—GRIK5—central nervous system—migraine	0.000199	0.00915	CbGeAlD
Topiramate—GRIK3—central nervous system—migraine	0.000199	0.00915	CbGeAlD
Topiramate—GRIK1—nervous system—migraine	0.000196	0.00903	CbGeAlD
Topiramate—GRIK3—cerebellum—migraine	0.000194	0.00894	CbGeAlD
Topiramate—GRIK5—cerebellum—migraine	0.000194	0.00894	CbGeAlD
Topiramate—GRIK3—Neuronal System—CACNA1A—migraine	0.000192	0.0169	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—CACNA1A—migraine	0.000192	0.0169	CbGpPWpGaD
Topiramate—GRIA3—head—migraine	0.000192	0.00885	CbGeAlD
Topiramate—GRIK1—central nervous system—migraine	0.000189	0.00869	CbGeAlD
Topiramate—GRIA1—brainstem—migraine	0.000186	0.00856	CbGeAlD
Topiramate—GRIK1—cerebellum—migraine	0.000185	0.0085	CbGeAlD
Topiramate—GRIA3—nervous system—migraine	0.000182	0.00839	CbGeAlD
Topiramate—CA4—nerve—migraine	0.00018	0.00828	CbGeAlD
Topiramate—SCN1A—L1CAM interactions—SCN2A—migraine	0.000178	0.0157	CbGpPWpGaD
Topiramate—GRIA3—central nervous system—migraine	0.000176	0.00808	CbGeAlD
Topiramate—GRIA3—cerebellum—migraine	0.000172	0.0079	CbGeAlD
Topiramate—GRIA4—brain—migraine	0.000171	0.00787	CbGeAlD
Topiramate—GRIA4—Neuronal System—CACNA1A—migraine	0.000164	0.0144	CbGpPWpGaD
Topiramate—GRIK3—brain—migraine	0.000158	0.00726	CbGeAlD
Topiramate—GRIK5—brain—migraine	0.000158	0.00726	CbGeAlD
Topiramate—GRIA3—Transmission across Chemical Synapses—CACNA1A—migraine	0.000155	0.0136	CbGpPWpGaD
Topiramate—GRIK1—brain—migraine	0.00015	0.0069	CbGeAlD
Topiramate—GRIA2—brainstem—migraine	0.000148	0.0068	CbGeAlD
Topiramate—SCN5A—L1CAM interactions—SCN1A—migraine	0.000147	0.013	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—KCNK18—migraine	0.000146	0.0128	CbGpPWpGaD
Topiramate—GRIA3—brain—migraine	0.000139	0.00642	CbGeAlD
Topiramate—SCN1A—brainstem—migraine	0.000135	0.0062	CbGeAlD
Topiramate—GRIK2—Neuronal System—KCNK18—migraine	0.000133	0.0117	CbGpPWpGaD
Topiramate—GRIK2—brainstem—migraine	0.000133	0.00614	CbGeAlD
Topiramate—SCN5A—L1CAM interactions—SCN2A—migraine	0.000125	0.011	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—CACNA1A—migraine	0.000119	0.0104	CbGpPWpGaD
Topiramate—GABRG2—trigeminal ganglion—migraine	0.000119	0.00546	CbGeAlD
Topiramate—GRIA1—Mecp2 and Associated Rett Syndrome—BDNF—migraine	0.000114	0.01	CbGpPWpGaD
Topiramate—GABRB2—Ion channel transport—TRPM8—migraine	0.000105	0.00927	CbGpPWpGaD
Topiramate—GABRB2—brainstem—migraine	0.000105	0.00483	CbGeAlD
Topiramate—GRIA1—head—migraine	0.000103	0.00473	CbGeAlD
Topiramate—CA6—head—migraine	0.000103	0.00473	CbGeAlD
Topiramate—GRIA2—Neuronal System—KCNK18—migraine	0.000102	0.00896	CbGpPWpGaD
Topiramate—CA4—neck—migraine	0.000101	0.00465	CbGeAlD
Topiramate—SCN5A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.0001	0.00878	CbGpPWpGaD
Topiramate—GRIA1—nervous system—migraine	9.74e-05	0.00448	CbGeAlD
Topiramate—GABRG2—Ion channel transport—TRPM8—migraine	9.65e-05	0.00848	CbGpPWpGaD
Topiramate—CA7—cerebellum—migraine	9.46e-05	0.00435	CbGeAlD
Topiramate—GRIA1—central nervous system—migraine	9.37e-05	0.00432	CbGeAlD
Topiramate—GRIA1—Transmission across Chemical Synapses—CACNA1A—migraine	9.3e-05	0.00817	CbGpPWpGaD
Topiramate—GABRA1—brainstem—migraine	9.27e-05	0.00427	CbGeAlD
Topiramate—GRIA1—cerebellum—migraine	9.16e-05	0.00422	CbGeAlD
Topiramate—CA5B—cardiovascular system—migraine	9.12e-05	0.0042	CbGeAlD
Topiramate—SCN5A—cardiovascular system—migraine	8.84e-05	0.00407	CbGeAlD
Topiramate—GRIK2—Transmission across Chemical Synapses—CACNA1A—migraine	8.5e-05	0.00747	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—HTR3A—migraine	8.5e-05	0.00747	CbGpPWpGaD
Topiramate—GABRA1—Ion channel transport—TRPM8—migraine	8.43e-05	0.00741	CbGpPWpGaD
Topiramate—CA2—neck—migraine	8.37e-05	0.00385	CbGeAlD
Topiramate—CA9—cerebellum—migraine	8.31e-05	0.00382	CbGeAlD
Topiramate—GRIA2—head—migraine	8.16e-05	0.00376	CbGeAlD
Topiramate—CA1—cardiovascular system—migraine	8.06e-05	0.00371	CbGeAlD
Topiramate—GABRB2—Ion channel transport—ATP1A2—migraine	8e-05	0.00702	CbGpPWpGaD
Topiramate—GABRB2—Ion channel transport—ATP1A3—migraine	8e-05	0.00702	CbGpPWpGaD
Topiramate—GRIA3—BDNF signaling pathway—BDNF—migraine	7.91e-05	0.00695	CbGpPWpGaD
Topiramate—GRIA2—nervous system—migraine	7.73e-05	0.00356	CbGeAlD
Topiramate—CA4—brainstem—migraine	7.72e-05	0.00355	CbGeAlD
Topiramate—CA7—brain—migraine	7.68e-05	0.00354	CbGeAlD
Topiramate—GABRB2—Neuronal System—KCNK18—migraine	7.66e-05	0.00673	CbGpPWpGaD
Topiramate—GRIA2—central nervous system—migraine	7.45e-05	0.00343	CbGeAlD
Topiramate—SCN1A—head—migraine	7.44e-05	0.00343	CbGeAlD
Topiramate—GRIA1—brain—migraine	7.44e-05	0.00343	CbGeAlD
Topiramate—GRIK2—head—migraine	7.37e-05	0.00339	CbGeAlD
Topiramate—GABRG2—Ion channel transport—ATP1A3—migraine	7.31e-05	0.00642	CbGpPWpGaD
Topiramate—GABRG2—Ion channel transport—ATP1A2—migraine	7.31e-05	0.00642	CbGpPWpGaD
Topiramate—GRIA2—cerebellum—migraine	7.28e-05	0.00335	CbGeAlD
Topiramate—CA2—trigeminal ganglion—migraine	7.23e-05	0.00333	CbGeAlD
Topiramate—GRIA1—Neuronal System—CACNA1A—migraine	7.12e-05	0.00626	CbGpPWpGaD
Topiramate—SCN1A—nervous system—migraine	7.06e-05	0.00325	CbGeAlD
Topiramate—GABRG2—Neuronal System—KCNK18—migraine	7.01e-05	0.00616	CbGpPWpGaD
Topiramate—GRIK2—nervous system—migraine	6.99e-05	0.00322	CbGeAlD
Topiramate—CA12—head—migraine	6.89e-05	0.00317	CbGeAlD
Topiramate—GABRB2—Ion channel transport—HTR3A—migraine	6.8e-05	0.00597	CbGpPWpGaD
Topiramate—SCN1A—central nervous system—migraine	6.79e-05	0.00313	CbGeAlD
Topiramate—SCN1A—Axon guidance—SCN2A—migraine	6.74e-05	0.00592	CbGpPWpGaD
Topiramate—GRIK2—central nervous system—migraine	6.73e-05	0.0031	CbGeAlD
Topiramate—SCN1A—cerebellum—migraine	6.64e-05	0.00306	CbGeAlD
Topiramate—GABRA1—SIDS Susceptibility Pathways—ATP1A3—migraine	6.59e-05	0.00579	CbGpPWpGaD
Topiramate—GRIK2—cerebellum—migraine	6.58e-05	0.00303	CbGeAlD
Topiramate—CA12—nervous system—migraine	6.53e-05	0.00301	CbGeAlD
Topiramate—GRIK2—Neuronal System—CACNA1A—migraine	6.51e-05	0.00572	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—CACNA1A—migraine	6.5e-05	0.00571	CbGpPWpGaD
Topiramate—CA2—brainstem—migraine	6.4e-05	0.00295	CbGeAlD
Topiramate—GABRA1—Ion channel transport—ATP1A2—migraine	6.39e-05	0.00561	CbGpPWpGaD
Topiramate—GABRA1—Ion channel transport—ATP1A3—migraine	6.39e-05	0.00561	CbGpPWpGaD
Topiramate—CA4—cardiovascular system—migraine	6.3e-05	0.0029	CbGeAlD
Topiramate—CA12—central nervous system—migraine	6.29e-05	0.00289	CbGeAlD
Topiramate—GABRG2—Ion channel transport—HTR3A—migraine	6.22e-05	0.00546	CbGpPWpGaD
Topiramate—CA5B—head—migraine	6.18e-05	0.00284	CbGeAlD
Topiramate—GABRA1—Neuronal System—KCNK18—migraine	6.13e-05	0.00538	CbGpPWpGaD
Topiramate—SCN5A—head—migraine	5.99e-05	0.00276	CbGeAlD
Topiramate—GRIA2—brain—migraine	5.91e-05	0.00272	CbGeAlD
Topiramate—CA5B—nervous system—migraine	5.86e-05	0.0027	CbGeAlD
Topiramate—GABRB2—head—migraine	5.8e-05	0.00267	CbGeAlD
Topiramate—GABRG2—head—migraine	5.8e-05	0.00267	CbGeAlD
Topiramate—SCN5A—nervous system—migraine	5.68e-05	0.00261	CbGeAlD
Topiramate—CA5B—central nervous system—migraine	5.64e-05	0.0026	CbGeAlD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HTR3A—migraine	5.6e-05	0.00492	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—SCN1A—migraine	5.57e-05	0.00489	CbGpPWpGaD
Topiramate—GABRB2—nervous system—migraine	5.5e-05	0.00253	CbGeAlD
Topiramate—GABRG2—nervous system—migraine	5.5e-05	0.00253	CbGeAlD
Topiramate—SCN5A—central nervous system—migraine	5.46e-05	0.00252	CbGeAlD
Topiramate—CA1—head—migraine	5.46e-05	0.00251	CbGeAlD
Topiramate—GABRA1—Ion channel transport—HTR3A—migraine	5.43e-05	0.00477	CbGpPWpGaD
Topiramate—SCN1A—brain—migraine	5.39e-05	0.00248	CbGeAlD
Topiramate—GRIA3—BDNF signaling pathway—FOS—migraine	5.35e-05	0.0047	CbGpPWpGaD
Topiramate—GRIK2—brain—migraine	5.34e-05	0.00246	CbGeAlD
Topiramate—GABRB2—central nervous system—migraine	5.3e-05	0.00244	CbGeAlD
Topiramate—GABRG2—central nervous system—migraine	5.3e-05	0.00244	CbGeAlD
Topiramate—CA2—cardiovascular system—migraine	5.22e-05	0.0024	CbGeAlD
Topiramate—GABRB2—cerebellum—migraine	5.18e-05	0.00238	CbGeAlD
Topiramate—GABRG2—cerebellum—migraine	5.18e-05	0.00238	CbGeAlD
Topiramate—CA1—nervous system—migraine	5.17e-05	0.00238	CbGeAlD
Topiramate—GABRA1—head—migraine	5.12e-05	0.00236	CbGeAlD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—TNF—migraine	5e-05	0.00439	CbGpPWpGaD
Topiramate—CA12—brain—migraine	4.99e-05	0.0023	CbGeAlD
Topiramate—GRIA2—Neuronal System—CACNA1A—migraine	4.98e-05	0.00438	CbGpPWpGaD
Topiramate—CA1—central nervous system—migraine	4.98e-05	0.00229	CbGeAlD
Topiramate—GABRB2—Transmission across Chemical Synapses—CACNA1A—migraine	4.88e-05	0.00429	CbGpPWpGaD
Topiramate—GABRA1—nervous system—migraine	4.86e-05	0.00224	CbGeAlD
Topiramate—SCN1A—Developmental Biology—SCN2A—migraine	4.81e-05	0.00422	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—BDNF—migraine	4.74e-05	0.00416	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—SCN2A—migraine	4.74e-05	0.00416	CbGpPWpGaD
Topiramate—GABRA1—central nervous system—migraine	4.68e-05	0.00215	CbGeAlD
Topiramate—CA9—HIF-1-alpha transcription factor network—FOS—migraine	4.61e-05	0.00405	CbGpPWpGaD
Topiramate—GABRA1—cerebellum—migraine	4.57e-05	0.0021	CbGeAlD
Topiramate—CA5B—brain—migraine	4.48e-05	0.00206	CbGeAlD
Topiramate—GABRG2—Transmission across Chemical Synapses—CACNA1A—migraine	4.47e-05	0.00392	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MEF2D—migraine	4.4e-05	0.00386	CbGpPWpGaD
Topiramate—SCN5A—brain—migraine	4.34e-05	0.002	CbGeAlD
Topiramate—CA4—head—migraine	4.26e-05	0.00196	CbGeAlD
Topiramate—GABRB2—brain—migraine	4.2e-05	0.00194	CbGeAlD
Topiramate—GABRG2—brain—migraine	4.2e-05	0.00194	CbGeAlD
Topiramate—CA4—nervous system—migraine	4.04e-05	0.00186	CbGeAlD
Topiramate—SCN5A—SIDS Susceptibility Pathways—HTR1A—migraine	4.04e-05	0.00355	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TAC1—migraine	3.98e-05	0.0035	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SCN1A—migraine	3.98e-05	0.00349	CbGpPWpGaD
Topiramate—CA1—brain—migraine	3.95e-05	0.00182	CbGeAlD
Topiramate—GABRA1—Transmission across Chemical Synapses—CACNA1A—migraine	3.9e-05	0.00343	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—SLC6A4—migraine	3.9e-05	0.00343	CbGpPWpGaD
Topiramate—CA4—central nervous system—migraine	3.89e-05	0.00179	CbGeAlD
Topiramate—CA4—cerebellum—migraine	3.8e-05	0.00175	CbGeAlD
Topiramate—GABRB2—Neuronal System—CACNA1A—migraine	3.74e-05	0.00329	CbGpPWpGaD
Topiramate—GABRA1—brain—migraine	3.71e-05	0.00171	CbGeAlD
Topiramate—GABRB2—Transmembrane transport of small molecules—TRPM8—migraine	3.67e-05	0.00323	CbGpPWpGaD
Topiramate—CA2—head—migraine	3.54e-05	0.00163	CbGeAlD
Topiramate—GABRG2—Neuronal System—CACNA1A—migraine	3.42e-05	0.00301	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—SCN2A—migraine	3.38e-05	0.00297	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—TRPM8—migraine	3.36e-05	0.00295	CbGpPWpGaD
Topiramate—CA2—nervous system—migraine	3.35e-05	0.00154	CbGeAlD
Topiramate—GRIA2—BDNF signaling pathway—BDNF—migraine	3.32e-05	0.00291	CbGpPWpGaD
Topiramate—CA2—central nervous system—migraine	3.23e-05	0.00149	CbGeAlD
Topiramate—GRIA1—BDNF signaling pathway—FOS—migraine	3.2e-05	0.00281	CbGpPWpGaD
Topiramate—CA2—cerebellum—migraine	3.15e-05	0.00145	CbGeAlD
Topiramate—SCN5A—Developmental Biology—MEF2D—migraine	3.09e-05	0.00272	CbGpPWpGaD
Topiramate—CA4—brain—migraine	3.09e-05	0.00142	CbGeAlD
Topiramate—GABRA1—Neuronal System—CACNA1A—migraine	2.99e-05	0.00263	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—TRPM8—migraine	2.94e-05	0.00258	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—BDNF—migraine	2.83e-05	0.00249	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ATP1A3—migraine	2.78e-05	0.00244	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ATP1A2—migraine	2.78e-05	0.00244	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HTR1A—migraine	2.66e-05	0.00234	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TAC1—migraine	2.62e-05	0.0023	CbGpPWpGaD
Topiramate—Dizziness—Amitriptyline—migraine	2.58e-05	0.000573	CcSEcCtD
Topiramate—Alopecia—Valproic Acid—migraine	2.58e-05	0.000572	CcSEcCtD
Topiramate—Dyspepsia—Verapamil—migraine	2.58e-05	0.000571	CcSEcCtD
Topiramate—Haematuria—Gabapentin—migraine	2.57e-05	0.00057	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—migraine	2.57e-05	0.00226	CbGpPWpGaD
Topiramate—CA2—brain—migraine	2.56e-05	0.00118	CbGeAlD
Topiramate—Oedema peripheral—Timolol—migraine	2.56e-05	0.000568	CcSEcCtD
Topiramate—Mental disorder—Valproic Acid—migraine	2.56e-05	0.000567	CcSEcCtD
Topiramate—Connective tissue disorder—Timolol—migraine	2.56e-05	0.000567	CcSEcCtD
Topiramate—GABRG2—Transmembrane transport of small molecules—ATP1A3—migraine	2.55e-05	0.00224	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ATP1A2—migraine	2.55e-05	0.00224	CbGpPWpGaD
Topiramate—Epistaxis—Gabapentin—migraine	2.54e-05	0.000564	CcSEcCtD
Topiramate—Malnutrition—Valproic Acid—migraine	2.54e-05	0.000564	CcSEcCtD
Topiramate—Sinusitis—Gabapentin—migraine	2.53e-05	0.000561	CcSEcCtD
Topiramate—Urticaria—Propranolol—migraine	2.53e-05	0.000561	CcSEcCtD
Topiramate—Fatigue—Verapamil—migraine	2.52e-05	0.00056	CcSEcCtD
Topiramate—Abdominal pain—Propranolol—migraine	2.52e-05	0.000558	CcSEcCtD
Topiramate—Body temperature increased—Propranolol—migraine	2.52e-05	0.000558	CcSEcCtD
Topiramate—Visual impairment—Timolol—migraine	2.51e-05	0.000556	CcSEcCtD
Topiramate—Flatulence—Valproic Acid—migraine	2.51e-05	0.000556	CcSEcCtD
Topiramate—Constipation—Verapamil—migraine	2.5e-05	0.000555	CcSEcCtD
Topiramate—Pain—Verapamil—migraine	2.5e-05	0.000555	CcSEcCtD
Topiramate—Tension—Valproic Acid—migraine	2.5e-05	0.000553	CcSEcCtD
Topiramate—Dysgeusia—Valproic Acid—migraine	2.49e-05	0.000552	CcSEcCtD
Topiramate—Vomiting—Amitriptyline—migraine	2.49e-05	0.000551	CcSEcCtD
Topiramate—CA6—Metabolism—CACNA1A—migraine	2.48e-05	0.00218	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CACNA1A—migraine	2.48e-05	0.00218	CbGpPWpGaD
Topiramate—Nervousness—Valproic Acid—migraine	2.47e-05	0.000548	CcSEcCtD
Topiramate—Bradycardia—Gabapentin—migraine	2.47e-05	0.000547	CcSEcCtD
Topiramate—Rash—Amitriptyline—migraine	2.46e-05	0.000546	CcSEcCtD
Topiramate—Dermatitis—Amitriptyline—migraine	2.46e-05	0.000546	CcSEcCtD
Topiramate—Back pain—Valproic Acid—migraine	2.46e-05	0.000545	CcSEcCtD
Topiramate—Headache—Amitriptyline—migraine	2.45e-05	0.000543	CcSEcCtD
Topiramate—Muscle spasms—Valproic Acid—migraine	2.45e-05	0.000542	CcSEcCtD
Topiramate—Eye disorder—Timolol—migraine	2.43e-05	0.000539	CcSEcCtD
Topiramate—Rhinitis—Gabapentin—migraine	2.43e-05	0.000538	CcSEcCtD
Topiramate—Tinnitus—Timolol—migraine	2.42e-05	0.000538	CcSEcCtD
Topiramate—Haemorrhage—Gabapentin—migraine	2.42e-05	0.000537	CcSEcCtD
Topiramate—Hepatitis—Gabapentin—migraine	2.42e-05	0.000537	CcSEcCtD
Topiramate—Cardiac disorder—Timolol—migraine	2.41e-05	0.000535	CcSEcCtD
Topiramate—Feeling abnormal—Verapamil—migraine	2.41e-05	0.000535	CcSEcCtD
Topiramate—Hypoaesthesia—Gabapentin—migraine	2.41e-05	0.000534	CcSEcCtD
Topiramate—Hallucination—Gabapentin—migraine	2.41e-05	0.000534	CcSEcCtD
Topiramate—Pharyngitis—Gabapentin—migraine	2.4e-05	0.000533	CcSEcCtD
Topiramate—Vision blurred—Valproic Acid—migraine	2.4e-05	0.000531	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—HTR2A—migraine	2.39e-05	0.0021	CbGpPWpGaD
Topiramate—Urinary tract disorder—Gabapentin—migraine	2.39e-05	0.00053	CcSEcCtD
Topiramate—Oedema peripheral—Gabapentin—migraine	2.39e-05	0.000529	CcSEcCtD
Topiramate—Tremor—Valproic Acid—migraine	2.38e-05	0.000528	CcSEcCtD
Topiramate—Connective tissue disorder—Gabapentin—migraine	2.38e-05	0.000528	CcSEcCtD
Topiramate—Urethral disorder—Gabapentin—migraine	2.37e-05	0.000526	CcSEcCtD
Topiramate—GABRB2—Transmembrane transport of small molecules—HTR3A—migraine	2.37e-05	0.00208	CbGpPWpGaD
Topiramate—Ill-defined disorder—Valproic Acid—migraine	2.36e-05	0.000523	CcSEcCtD
Topiramate—Angiopathy—Timolol—migraine	2.36e-05	0.000523	CcSEcCtD
Topiramate—Anaemia—Valproic Acid—migraine	2.35e-05	0.000521	CcSEcCtD
Topiramate—Immune system disorder—Timolol—migraine	2.35e-05	0.000521	CcSEcCtD
Topiramate—Hypersensitivity—Propranolol—migraine	2.34e-05	0.00052	CcSEcCtD
Topiramate—Mediastinal disorder—Timolol—migraine	2.34e-05	0.00052	CcSEcCtD
Topiramate—Agitation—Valproic Acid—migraine	2.34e-05	0.000518	CcSEcCtD
Topiramate—Visual impairment—Gabapentin—migraine	2.33e-05	0.000517	CcSEcCtD
Topiramate—Urticaria—Verapamil—migraine	2.33e-05	0.000516	CcSEcCtD
Topiramate—Nausea—Amitriptyline—migraine	2.32e-05	0.000515	CcSEcCtD
Topiramate—CA5B—Metabolism—CACNA1A—migraine	2.32e-05	0.00203	CbGpPWpGaD
Topiramate—CA7—Metabolism—CACNA1A—migraine	2.32e-05	0.00203	CbGpPWpGaD
Topiramate—Alopecia—Timolol—migraine	2.3e-05	0.00051	CcSEcCtD
Topiramate—Malaise—Valproic Acid—migraine	2.29e-05	0.000509	CcSEcCtD
Topiramate—Erythema multiforme—Gabapentin—migraine	2.29e-05	0.000508	CcSEcCtD
Topiramate—Vertigo—Valproic Acid—migraine	2.28e-05	0.000507	CcSEcCtD
Topiramate—Asthenia—Propranolol—migraine	2.28e-05	0.000506	CcSEcCtD
Topiramate—Mental disorder—Timolol—migraine	2.28e-05	0.000505	CcSEcCtD
Topiramate—Leukopenia—Valproic Acid—migraine	2.28e-05	0.000505	CcSEcCtD
Topiramate—Erythema—Timolol—migraine	2.26e-05	0.000502	CcSEcCtD
Topiramate—Malnutrition—Timolol—migraine	2.26e-05	0.000502	CcSEcCtD
Topiramate—Eye disorder—Gabapentin—migraine	2.26e-05	0.000502	CcSEcCtD
Topiramate—Tinnitus—Gabapentin—migraine	2.26e-05	0.000501	CcSEcCtD
Topiramate—Cardiac disorder—Gabapentin—migraine	2.25e-05	0.000498	CcSEcCtD
Topiramate—Palpitations—Valproic Acid—migraine	2.25e-05	0.000498	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—FOS—migraine	2.24e-05	0.00197	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ATP1A2—migraine	2.22e-05	0.00195	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ATP1A3—migraine	2.22e-05	0.00195	CbGpPWpGaD
Topiramate—Tension—Timolol—migraine	2.22e-05	0.000493	CcSEcCtD
Topiramate—Cough—Valproic Acid—migraine	2.22e-05	0.000492	CcSEcCtD
Topiramate—Dysgeusia—Timolol—migraine	2.22e-05	0.000492	CcSEcCtD
Topiramate—Nervousness—Timolol—migraine	2.2e-05	0.000488	CcSEcCtD
Topiramate—Hypertension—Valproic Acid—migraine	2.2e-05	0.000487	CcSEcCtD
Topiramate—Immune system disorder—Gabapentin—migraine	2.19e-05	0.000485	CcSEcCtD
Topiramate—Mediastinal disorder—Gabapentin—migraine	2.18e-05	0.000484	CcSEcCtD
Topiramate—Diarrhoea—Propranolol—migraine	2.18e-05	0.000483	CcSEcCtD
Topiramate—Chills—Gabapentin—migraine	2.17e-05	0.000482	CcSEcCtD
Topiramate—Myalgia—Valproic Acid—migraine	2.17e-05	0.00048	CcSEcCtD
Topiramate—Chest pain—Valproic Acid—migraine	2.17e-05	0.00048	CcSEcCtD
Topiramate—Arthralgia—Valproic Acid—migraine	2.17e-05	0.00048	CcSEcCtD
Topiramate—GABRG2—Transmembrane transport of small molecules—HTR3A—migraine	2.16e-05	0.0019	CbGpPWpGaD
Topiramate—CYP3A4—nervous system—migraine	2.16e-05	0.000996	CbGeAlD
Topiramate—Anxiety—Valproic Acid—migraine	2.16e-05	0.000478	CcSEcCtD
Topiramate—Hypersensitivity—Verapamil—migraine	2.16e-05	0.000478	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	2.15e-05	0.000477	CcSEcCtD
Topiramate—CA12—Metabolism—CACNA1A—migraine	2.15e-05	0.00189	CbGpPWpGaD
Topiramate—Alopecia—Gabapentin—migraine	2.14e-05	0.000475	CcSEcCtD
Topiramate—Discomfort—Valproic Acid—migraine	2.14e-05	0.000474	CcSEcCtD
Topiramate—Vision blurred—Timolol—migraine	2.13e-05	0.000473	CcSEcCtD
Topiramate—Mental disorder—Gabapentin—migraine	2.12e-05	0.00047	CcSEcCtD
Topiramate—Dry mouth—Valproic Acid—migraine	2.12e-05	0.00047	CcSEcCtD
Topiramate—Erythema—Gabapentin—migraine	2.11e-05	0.000467	CcSEcCtD
Topiramate—Malnutrition—Gabapentin—migraine	2.11e-05	0.000467	CcSEcCtD
Topiramate—Dizziness—Propranolol—migraine	2.1e-05	0.000467	CcSEcCtD
Topiramate—Asthenia—Verapamil—migraine	2.1e-05	0.000466	CcSEcCtD
Topiramate—Confusional state—Valproic Acid—migraine	2.09e-05	0.000464	CcSEcCtD
Topiramate—CYP3A4—central nervous system—migraine	2.08e-05	0.000959	CbGeAlD
Topiramate—Flatulence—Gabapentin—migraine	2.08e-05	0.000461	CcSEcCtD
Topiramate—Oedema—Valproic Acid—migraine	2.08e-05	0.00046	CcSEcCtD
Topiramate—Pruritus—Verapamil—migraine	2.07e-05	0.000459	CcSEcCtD
Topiramate—Tension—Gabapentin—migraine	2.07e-05	0.000459	CcSEcCtD
Topiramate—Dysgeusia—Gabapentin—migraine	2.06e-05	0.000458	CcSEcCtD
Topiramate—Infection—Valproic Acid—migraine	2.06e-05	0.000457	CcSEcCtD
Topiramate—Nervousness—Gabapentin—migraine	2.05e-05	0.000454	CcSEcCtD
Topiramate—Back pain—Gabapentin—migraine	2.04e-05	0.000452	CcSEcCtD
Topiramate—Nervous system disorder—Valproic Acid—migraine	2.04e-05	0.000451	CcSEcCtD
Topiramate—Vertigo—Timolol—migraine	2.03e-05	0.000451	CcSEcCtD
Topiramate—Thrombocytopenia—Valproic Acid—migraine	2.03e-05	0.000451	CcSEcCtD
Topiramate—Syncope—Timolol—migraine	2.03e-05	0.00045	CcSEcCtD
Topiramate—Muscle spasms—Gabapentin—migraine	2.03e-05	0.000449	CcSEcCtD
Topiramate—Tachycardia—Valproic Acid—migraine	2.03e-05	0.000449	CcSEcCtD
Topiramate—Vomiting—Propranolol—migraine	2.02e-05	0.000449	CcSEcCtD
Topiramate—Skin disorder—Valproic Acid—migraine	2.02e-05	0.000447	CcSEcCtD
Topiramate—Hyperhidrosis—Valproic Acid—migraine	2.01e-05	0.000445	CcSEcCtD
Topiramate—Rash—Propranolol—migraine	2.01e-05	0.000445	CcSEcCtD
Topiramate—Dermatitis—Propranolol—migraine	2e-05	0.000444	CcSEcCtD
Topiramate—Diarrhoea—Verapamil—migraine	2e-05	0.000444	CcSEcCtD
Topiramate—Palpitations—Timolol—migraine	2e-05	0.000444	CcSEcCtD
Topiramate—Loss of consciousness—Timolol—migraine	1.99e-05	0.000441	CcSEcCtD
Topiramate—Vision blurred—Gabapentin—migraine	1.99e-05	0.000441	CcSEcCtD
Topiramate—Anorexia—Valproic Acid—migraine	1.98e-05	0.000439	CcSEcCtD
Topiramate—Cough—Timolol—migraine	1.98e-05	0.000438	CcSEcCtD
Topiramate—Tremor—Gabapentin—migraine	1.98e-05	0.000438	CcSEcCtD
Topiramate—Ill-defined disorder—Gabapentin—migraine	1.96e-05	0.000434	CcSEcCtD
Topiramate—Hypertension—Timolol—migraine	1.95e-05	0.000433	CcSEcCtD
Topiramate—Anaemia—Gabapentin—migraine	1.95e-05	0.000432	CcSEcCtD
Topiramate—Hypotension—Valproic Acid—migraine	1.94e-05	0.00043	CcSEcCtD
Topiramate—Agitation—Gabapentin—migraine	1.94e-05	0.00043	CcSEcCtD
Topiramate—Dizziness—Verapamil—migraine	1.94e-05	0.000429	CcSEcCtD
Topiramate—Chest pain—Timolol—migraine	1.93e-05	0.000427	CcSEcCtD
Topiramate—Myalgia—Timolol—migraine	1.93e-05	0.000427	CcSEcCtD
Topiramate—Arthralgia—Timolol—migraine	1.93e-05	0.000427	CcSEcCtD
Topiramate—Anxiety—Timolol—migraine	1.92e-05	0.000426	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	1.91e-05	0.000424	CcSEcCtD
Topiramate—Discomfort—Timolol—migraine	1.9e-05	0.000422	CcSEcCtD
Topiramate—Malaise—Gabapentin—migraine	1.9e-05	0.000422	CcSEcCtD
Topiramate—Vertigo—Gabapentin—migraine	1.89e-05	0.00042	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—HTR3A—migraine	1.89e-05	0.00166	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Valproic Acid—migraine	1.89e-05	0.000419	CcSEcCtD
Topiramate—Syncope—Gabapentin—migraine	1.89e-05	0.000419	CcSEcCtD
Topiramate—Nausea—Propranolol—migraine	1.89e-05	0.000419	CcSEcCtD
Topiramate—Leukopenia—Gabapentin—migraine	1.89e-05	0.000418	CcSEcCtD
Topiramate—Dry mouth—Timolol—migraine	1.89e-05	0.000418	CcSEcCtD
Topiramate—Insomnia—Valproic Acid—migraine	1.88e-05	0.000416	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—BDNF—migraine	1.87e-05	0.00164	CbGpPWpGaD
Topiramate—Paraesthesia—Valproic Acid—migraine	1.86e-05	0.000413	CcSEcCtD
Topiramate—Palpitations—Gabapentin—migraine	1.86e-05	0.000413	CcSEcCtD
Topiramate—Confusional state—Timolol—migraine	1.86e-05	0.000413	CcSEcCtD
Topiramate—Vomiting—Verapamil—migraine	1.86e-05	0.000413	CcSEcCtD
Topiramate—Loss of consciousness—Gabapentin—migraine	1.85e-05	0.000411	CcSEcCtD
Topiramate—Dyspnoea—Valproic Acid—migraine	1.85e-05	0.00041	CcSEcCtD
Topiramate—Oedema—Timolol—migraine	1.85e-05	0.00041	CcSEcCtD
Topiramate—Rash—Verapamil—migraine	1.85e-05	0.000409	CcSEcCtD
Topiramate—Somnolence—Valproic Acid—migraine	1.85e-05	0.000409	CcSEcCtD
Topiramate—Dermatitis—Verapamil—migraine	1.84e-05	0.000409	CcSEcCtD
Topiramate—Cough—Gabapentin—migraine	1.84e-05	0.000408	CcSEcCtD
Topiramate—Infection—Timolol—migraine	1.84e-05	0.000407	CcSEcCtD
Topiramate—Headache—Verapamil—migraine	1.83e-05	0.000407	CcSEcCtD
Topiramate—Dyspepsia—Valproic Acid—migraine	1.83e-05	0.000405	CcSEcCtD
Topiramate—Convulsion—Gabapentin—migraine	1.83e-05	0.000405	CcSEcCtD
Topiramate—Hypertension—Gabapentin—migraine	1.82e-05	0.000404	CcSEcCtD
Topiramate—Shock—Timolol—migraine	1.82e-05	0.000403	CcSEcCtD
Topiramate—Nervous system disorder—Timolol—migraine	1.81e-05	0.000402	CcSEcCtD
Topiramate—Decreased appetite—Valproic Acid—migraine	1.8e-05	0.0004	CcSEcCtD
Topiramate—Arthralgia—Gabapentin—migraine	1.79e-05	0.000398	CcSEcCtD
Topiramate—Myalgia—Gabapentin—migraine	1.79e-05	0.000398	CcSEcCtD
Topiramate—Chest pain—Gabapentin—migraine	1.79e-05	0.000398	CcSEcCtD
Topiramate—Skin disorder—Timolol—migraine	1.79e-05	0.000398	CcSEcCtD
Topiramate—Gastrointestinal disorder—Valproic Acid—migraine	1.79e-05	0.000397	CcSEcCtD
Topiramate—Fatigue—Valproic Acid—migraine	1.79e-05	0.000397	CcSEcCtD
Topiramate—Anxiety—Gabapentin—migraine	1.79e-05	0.000397	CcSEcCtD
Topiramate—Hyperhidrosis—Timolol—migraine	1.79e-05	0.000396	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	1.78e-05	0.000395	CcSEcCtD
Topiramate—Pain—Valproic Acid—migraine	1.77e-05	0.000394	CcSEcCtD
Topiramate—Constipation—Valproic Acid—migraine	1.77e-05	0.000394	CcSEcCtD
Topiramate—Discomfort—Gabapentin—migraine	1.77e-05	0.000393	CcSEcCtD
Topiramate—Anorexia—Timolol—migraine	1.76e-05	0.000391	CcSEcCtD
Topiramate—Dry mouth—Gabapentin—migraine	1.76e-05	0.000389	CcSEcCtD
Topiramate—Nausea—Verapamil—migraine	1.74e-05	0.000386	CcSEcCtD
Topiramate—Confusional state—Gabapentin—migraine	1.73e-05	0.000385	CcSEcCtD
Topiramate—Hypotension—Timolol—migraine	1.73e-05	0.000383	CcSEcCtD
Topiramate—Oedema—Gabapentin—migraine	1.72e-05	0.000382	CcSEcCtD
Topiramate—CA4—Metabolism—CACNA1A—migraine	1.71e-05	0.0015	CbGpPWpGaD
Topiramate—Feeling abnormal—Valproic Acid—migraine	1.71e-05	0.000379	CcSEcCtD
Topiramate—Infection—Gabapentin—migraine	1.71e-05	0.000379	CcSEcCtD
Topiramate—Gastrointestinal pain—Valproic Acid—migraine	1.7e-05	0.000376	CcSEcCtD
Topiramate—Shock—Gabapentin—migraine	1.69e-05	0.000375	CcSEcCtD
Topiramate—Nervous system disorder—Gabapentin—migraine	1.69e-05	0.000374	CcSEcCtD
Topiramate—Thrombocytopenia—Gabapentin—migraine	1.68e-05	0.000374	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Timolol—migraine	1.68e-05	0.000373	CcSEcCtD
Topiramate—Tachycardia—Gabapentin—migraine	1.68e-05	0.000372	CcSEcCtD
Topiramate—Skin disorder—Gabapentin—migraine	1.67e-05	0.000371	CcSEcCtD
Topiramate—Insomnia—Timolol—migraine	1.67e-05	0.000371	CcSEcCtD
Topiramate—Hyperhidrosis—Gabapentin—migraine	1.66e-05	0.000369	CcSEcCtD
Topiramate—Paraesthesia—Timolol—migraine	1.66e-05	0.000368	CcSEcCtD
Topiramate—Urticaria—Valproic Acid—migraine	1.65e-05	0.000366	CcSEcCtD
Topiramate—Dyspnoea—Timolol—migraine	1.65e-05	0.000365	CcSEcCtD
Topiramate—Somnolence—Timolol—migraine	1.64e-05	0.000364	CcSEcCtD
Topiramate—Body temperature increased—Valproic Acid—migraine	1.64e-05	0.000364	CcSEcCtD
Topiramate—Abdominal pain—Valproic Acid—migraine	1.64e-05	0.000364	CcSEcCtD
Topiramate—CA2—Metabolism—CACNA1A—migraine	1.64e-05	0.00144	CbGpPWpGaD
Topiramate—Anorexia—Gabapentin—migraine	1.64e-05	0.000364	CcSEcCtD
Topiramate—Dyspepsia—Timolol—migraine	1.63e-05	0.000361	CcSEcCtD
Topiramate—Hypotension—Gabapentin—migraine	1.61e-05	0.000356	CcSEcCtD
Topiramate—Decreased appetite—Timolol—migraine	1.61e-05	0.000356	CcSEcCtD
Topiramate—Gastrointestinal disorder—Timolol—migraine	1.6e-05	0.000354	CcSEcCtD
Topiramate—Fatigue—Timolol—migraine	1.59e-05	0.000353	CcSEcCtD
Topiramate—Pain—Timolol—migraine	1.58e-05	0.00035	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HTR2A—migraine	1.58e-05	0.00139	CbGpPWpGaD
Topiramate—CA1—Metabolism—CACNA1A—migraine	1.57e-05	0.00138	CbGpPWpGaD
Topiramate—Musculoskeletal discomfort—Gabapentin—migraine	1.57e-05	0.000348	CcSEcCtD
Topiramate—Insomnia—Gabapentin—migraine	1.56e-05	0.000345	CcSEcCtD
Topiramate—Paraesthesia—Gabapentin—migraine	1.55e-05	0.000343	CcSEcCtD
Topiramate—Dyspnoea—Gabapentin—migraine	1.53e-05	0.00034	CcSEcCtD
Topiramate—Somnolence—Gabapentin—migraine	1.53e-05	0.000339	CcSEcCtD
Topiramate—Hypersensitivity—Valproic Acid—migraine	1.53e-05	0.000339	CcSEcCtD
Topiramate—Feeling abnormal—Timolol—migraine	1.52e-05	0.000338	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—FOS—migraine	1.52e-05	0.00134	CbGpPWpGaD
Topiramate—Dyspepsia—Gabapentin—migraine	1.51e-05	0.000336	CcSEcCtD
Topiramate—Gastrointestinal pain—Timolol—migraine	1.51e-05	0.000335	CcSEcCtD
Topiramate—Decreased appetite—Gabapentin—migraine	1.5e-05	0.000332	CcSEcCtD
Topiramate—Asthenia—Valproic Acid—migraine	1.49e-05	0.00033	CcSEcCtD
Topiramate—Gastrointestinal disorder—Gabapentin—migraine	1.49e-05	0.000329	CcSEcCtD
Topiramate—Fatigue—Gabapentin—migraine	1.48e-05	0.000329	CcSEcCtD
Topiramate—Constipation—Gabapentin—migraine	1.47e-05	0.000326	CcSEcCtD
Topiramate—Pain—Gabapentin—migraine	1.47e-05	0.000326	CcSEcCtD
Topiramate—Pruritus—Valproic Acid—migraine	1.47e-05	0.000326	CcSEcCtD
Topiramate—Urticaria—Timolol—migraine	1.47e-05	0.000325	CcSEcCtD
Topiramate—Abdominal pain—Timolol—migraine	1.46e-05	0.000324	CcSEcCtD
Topiramate—Body temperature increased—Timolol—migraine	1.46e-05	0.000324	CcSEcCtD
Topiramate—Diarrhoea—Valproic Acid—migraine	1.42e-05	0.000315	CcSEcCtD
Topiramate—Feeling abnormal—Gabapentin—migraine	1.42e-05	0.000314	CcSEcCtD
Topiramate—Gastrointestinal pain—Gabapentin—migraine	1.41e-05	0.000312	CcSEcCtD
Topiramate—CA9—Metabolism—CACNA1A—migraine	1.38e-05	0.00121	CbGpPWpGaD
Topiramate—Dizziness—Valproic Acid—migraine	1.37e-05	0.000304	CcSEcCtD
Topiramate—Urticaria—Gabapentin—migraine	1.37e-05	0.000303	CcSEcCtD
Topiramate—Hypersensitivity—Timolol—migraine	1.36e-05	0.000302	CcSEcCtD
Topiramate—Body temperature increased—Gabapentin—migraine	1.36e-05	0.000302	CcSEcCtD
Topiramate—Abdominal pain—Gabapentin—migraine	1.36e-05	0.000302	CcSEcCtD
Topiramate—Asthenia—Timolol—migraine	1.33e-05	0.000294	CcSEcCtD
Topiramate—Vomiting—Valproic Acid—migraine	1.32e-05	0.000293	CcSEcCtD
Topiramate—Rash—Valproic Acid—migraine	1.31e-05	0.00029	CcSEcCtD
Topiramate—Dermatitis—Valproic Acid—migraine	1.31e-05	0.00029	CcSEcCtD
Topiramate—Pruritus—Timolol—migraine	1.31e-05	0.00029	CcSEcCtD
Topiramate—Headache—Valproic Acid—migraine	1.3e-05	0.000288	CcSEcCtD
Topiramate—Hypersensitivity—Gabapentin—migraine	1.27e-05	0.000281	CcSEcCtD
Topiramate—Diarrhoea—Timolol—migraine	1.26e-05	0.00028	CcSEcCtD
Topiramate—Asthenia—Gabapentin—migraine	1.23e-05	0.000274	CcSEcCtD
Topiramate—Nausea—Valproic Acid—migraine	1.23e-05	0.000273	CcSEcCtD
Topiramate—Dizziness—Timolol—migraine	1.22e-05	0.000271	CcSEcCtD
Topiramate—Pruritus—Gabapentin—migraine	1.22e-05	0.00027	CcSEcCtD
Topiramate—Diarrhoea—Gabapentin—migraine	1.18e-05	0.000261	CcSEcCtD
Topiramate—Vomiting—Timolol—migraine	1.17e-05	0.00026	CcSEcCtD
Topiramate—Rash—Timolol—migraine	1.17e-05	0.000258	CcSEcCtD
Topiramate—Dermatitis—Timolol—migraine	1.16e-05	0.000258	CcSEcCtD
Topiramate—Headache—Timolol—migraine	1.16e-05	0.000257	CcSEcCtD
Topiramate—Dizziness—Gabapentin—migraine	1.14e-05	0.000252	CcSEcCtD
Topiramate—Nausea—Timolol—migraine	1.1e-05	0.000243	CcSEcCtD
Topiramate—Vomiting—Gabapentin—migraine	1.09e-05	0.000243	CcSEcCtD
Topiramate—Rash—Gabapentin—migraine	1.08e-05	0.000241	CcSEcCtD
Topiramate—Dermatitis—Gabapentin—migraine	1.08e-05	0.00024	CcSEcCtD
Topiramate—Headache—Gabapentin—migraine	1.08e-05	0.000239	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—migraine	1.03e-05	0.000905	CbGpPWpGaD
Topiramate—Nausea—Gabapentin—migraine	1.02e-05	0.000227	CcSEcCtD
Topiramate—CA6—Metabolism—MTHFR—migraine	8.21e-06	0.000721	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MTHFR—migraine	8.21e-06	0.000721	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MTHFR—migraine	7.66e-06	0.000673	CbGpPWpGaD
Topiramate—CA7—Metabolism—MTHFR—migraine	7.66e-06	0.000673	CbGpPWpGaD
Topiramate—CA12—Metabolism—MTHFR—migraine	7.1e-06	0.000624	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—migraine	6.78e-06	0.000596	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—migraine	5.82e-06	0.000512	CbGpPWpGaD
Topiramate—CA4—Metabolism—MTHFR—migraine	5.66e-06	0.000497	CbGpPWpGaD
Topiramate—CA2—Metabolism—MTHFR—migraine	5.43e-06	0.000477	CbGpPWpGaD
Topiramate—CA1—Metabolism—MTHFR—migraine	5.2e-06	0.000457	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—migraine	4.57e-06	0.000402	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—migraine	4.09e-06	0.00036	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CACNA1A—migraine	3.87e-06	0.00034	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CACNA1A—migraine	2.33e-06	0.000204	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—migraine	1.28e-06	0.000112	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—migraine	7.7e-07	6.76e-05	CbGpPWpGaD
